Anticoagulation Therapy After Splenectomy in Cirrhosis Patient

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Liver CirrhosisPortal HypertensionAnticoagulant-induced BleedingThrombosis
Interventions
DRUG

Heparin and Rivaroxaban

Low molecular weight heparin 5000U ih Q12h was given 24 hours after operation, 5 days after operation Rivaroxaban 10mg PO QD from 24 hours after operation, 30 days after operation

Trial Locations (1)

710061

the first hospital of xi'an jiaotong University, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT04397289 - Anticoagulation Therapy After Splenectomy in Cirrhosis Patient | Biotech Hunter | Biotech Hunter